To this regard, we observed that melanoma as well as NSCLC cells, having relative higher levels of endogenous Bcl-2 and Mcl-1 proteins, respect to breast and colon cancer cells, were more sensitive to treatment. This evidence concerns the gene MCL1 and malignant colon neoplasm.